Programmed death-ligand 1 also known as cluster of differentiation 274 or B7 homolog 1 is a protein that in humans is encoded by the CD274 gene. From Wikipedia
Presented at ASCO, the phase II study indicates that adding cetuximab to avelumab may offer a new treatment path for patients who progress after initial PD-1 therapy.